Visual Prosthesis

Total Page:16

File Type:pdf, Size:1020Kb

Visual Prosthesis INVITED PAPER Visual Prosthesis Microelectronic implants that provide identification of simple objects and motion detection for blind patients have been tested and evaluated; further development is needed for face recognition and reading implants. By James D. Weiland and Mark S. Humayun ABSTRACT | Electronic visual prostheses have demonstrated requirements for a parallel neural interface and power the ability to restore a rudimentary sense of vision to blind efficiency that make certain engineering challenges impor- individuals. This review paper will highlight past and recent tant to all visual implants. This paper will review the causes progress in this field as well as some technical challenges to of blindness, the microelectronic approaches to treating further advancement. Retinal implants have now been tested in blindness, and technology needs to enable future implants. humans by four independent groups. Optic nerve and cortical implants have been also been evaluated in humans. The first implants have achieved remarkable results, including detection II. CAUSES OF BLINDNESS of motion and distinguishing objects from a set. To improve on Blindness can result from damage to the optical pathway these results, a number of research groups have performed (cornea, aqueous humor, crystalline lens, and vitreous simulations that predict up to 1000 individual pixels may be Fig. 3) that focuses light on the retina or damage to the needed to restore significant functions such as face recognition visual neurons that sense light and send visual information and reading. In order to achieve a device that can stimulate the to the brain. We will review only the neural diseases, but it is visual system in this many locations, issues of power con- worth noting that cataracts (opacities in the crystalline lens) sumption and electronic packaging must be resolved. are a major cause of blindness worldwide.1 An excellent review of the retina and vision can be found online.2 KEYWORDS | Electrical stimulation; implantable medical pack- Blindness has a significant impact on the economy. aging; medical implants; neural prosthesis; retinal prosthesis Recent studies have found that only 29% of severely visually impaired persons are gainfully employed, com- pared with a national average of 84% [1]. Persons with I. INTRODUCTION severe visual impairment earn 37% per year less than their Photoreceptors are the specialized neurons in the eye that able bodied counterparts [2]. The total economic impact convert photons into a neural signal (Fig. 1). The of vision loss in the United States is estimated at nearly photoreceptors are part of the retina, a multilayer neural $68 billion annually.3 structure about 200 m thick that lines the back of the eye. The two most common retinal degenerative diseases that Other cells in the retina process the signal from the result in blindness secondary to photoreceptor loss are age- photoreceptors. Retinal ganglion cells send the processed related macular degeneration (AMD) and retinitis pigmen- signal from the retina to the brain via the optic nerve. tosa (RP). RP is generally more severe, and its symptoms Blindness can result when any part of this visual pathway is appear earlier in life, but AMD is more prevalent. In the damaged by injury or disease. Electronic visual prostheses United States, there are approximately 700 000 new AMD are being developed that can be implanted in different patients; each year, 70 000 of these patients will become anatomical locations along the visual pathway (Fig. 2). While legally blind, with many more suffering significant vision the final implementation of the implant will depend on the loss [3]. AMD results from a slow degeneration of the anatomy of the targeted area, visual prostheses have common photoreceptor cells of the retina, ultimately culminating in photoreceptor cell death. This is sometimes accompanied by Manuscript received August 14, 2007; revised January 14, 2008. 1See World Health Organization, www.who.int/mediacentre/ The authors are with Doheny Eye Institute, University of Southern California, factsheets/fs282/en/. Los Angeles, CA 90033 USA (e-mail: [email protected]; [email protected]). 2www.webvision.med.utah.edu/. 3 Digital Object Identifier: 10.1109/JPROC.2008.922589 See http://www.silverbook.org/visionloss. 1076 Proceedings of the IEEE | Vol. 96, No. 7, July 2008 0018-9219/$25.00 Ó2008 IEEE Weiland and Humayun: Visual Prosthesis Fig. 1. Cross-section of the retina. The photoreceptors (rods and cones) convert photons into neurochemical energy, which is relayed through the retina. The different layers of the retina process the image signal. The output of the retina comes from the retinal ganglion cells, whose axons gather at the optic disc to form the optic nerve. In retinitis pigmentosa and age-related macular degeneration, the photoreceptors are degenerated but the other layers of the retina remain. (Image courtesy of Webvision, webvision.med.utah.edu.) Fig. 2. Human visual system. The optic nerve transmits retinal information to the lateral geniculate, which relays the information to the primary visual cortex (striate cortex or V1). (Image courtesy of Webvision, webvision.med.utah.edu.) Vol. 96, No. 7, July 2008 | Proceedings of the IEEE 1077 Weiland and Humayun: Visual Prosthesis lating electrode array. Implants in humans have been tested in the retina, visual cortex, and optic nerve. Recent clinical trials of retinal implants have included epiretinal implants [7]–[10], a passive subretinal device [11], and an active subretinal device [12] (see Fig. 4). Passive devices rely on incident light for power, whereas active devices have an external power source. All of the devices currently being tested are manufactured by companies, which have the required quality systems and manufacturing skills to produce robust, medical-grade implants. The trials reviewed below will be referred to by the company that produced the implant. The first clinical trial of a permanently implanted retinal prosthesis was initiated by Optobionics, Inc., in 2000.Thedevicewasapassivemicrophotodiodearray with 3500 elements. Subjects in the passive subretinal trial Fig. 3. Cross-section of a human eye. Light is focused by the cornea do not report pixelized vision, as might be expected if each and lens on the retina. The retina lines the posterior of the eye. photodiode were acting as a photoreceptor [11]. However, (Image from http://www.nei.nih.gov/health/cataract/ some of the subjects have reported improved visual cataract_facts.asp.) function away from the implant site, suggesting that the presence of the implant alone, or coupled with low-level electrical stimulation, induced a Bneurotrophic effect[ the formation of new blood vessels. Individuals afflicted that improved the health of the retina and consequently with AMD will start to have distorted central vision and improved visual function. eventually will lose most vision in the central 30 of visual A prototype epiretinal implant with 16 electrodes is field, rendering them legally blind (less than 20/200 vision). beingtestedbySecondSightMedicalProducts,Inc. RP is a collective name for a number of genetic defects that (Sylmar, CA). This trial began in 2002 and has enrolled also result in photoreceptor loss [4]. More than 100 genetic six individuals with bare light perception secondary to RP. defects have been identified that cause the different forms of Test subjects can use spatial information from the RP. The overall incidence of RP is 1 in 3500 live births. In stimulator to detect motion and locate objects [9]. general, RP strikes the rod photoreceptor cells first, Subjects demonstrated their ability to distinguish between resulting in poor night vision and loss of peripheral vision. three common objects (plate, cup, and knife) at levels Eventually, cone photoreceptors, which mediate color and statistically above chance. Subjects have also demonstrat- daytime vision, are lost, leading to complete blindness. ed that they can discern the direction of motion of a bar Neither AMD nor RP is presently curable through surgery passed in front of the camera. Recent reports involve or treatment, but there are some treatments that can slow detection of the orientation of a black and white grating the progression of AMD [5]. pattern [13]. A subject was able to detect these gratings at Diseases that damage the optic nerve include diabetic 4 increasing spatial frequency up to the theoretical limit retinopathy and glaucoma. In diabetic retinopathy, retinal predicted by the electrode spacing on the retina. blood vessel abnormalities can prevent nourishment from Perceptual thresholds are in general low, compared to reaching neural cells in the retina, leading to ganglion cell the earlier short-term implants [8]. Some subjects have and optic nerve damage. Glaucoma often includes high shown a majority of electrodes with a perceptual intraocular pressure as a symptom. In the past, it was thought threshold below 50 A (1 ms pulse), with a range of that high eye pressure was damaging to the retina and led to 24–702 A(1mspulse)reportedacrossthreesubjects.A ganglion cell and optic nerve loss, but more recently it has second clinical trial of an epiretinal implant, built by been found that even individuals with normal eye pressure Intelligent Medical Implants AG (Zurich, Switzerland), can have optic nerve damage from glaucoma [6]. has recently begun. This implant features a microfabri- A. Visual Prostheses cated electrode array of 49 platinum electrodes on a polyimide
Recommended publications
  • View Article (Pdf)
    State-of-the-Art Review Section Editors: Grant T. Liu, MD Randy H. Kardon, MD, PhD Update on Retinal Prosthetic Research: The Boston Retinal Implant Project Joseph F. Rizzo III, MD Abstract: The field of retinal prosthetic research, now more pathway in the retina, optic nerve, lateral geniculate body, than 20 years old, has produced many high-quality technical and the primary or higher visual cortical regions. Each options that have the potential to restore vision to patients approach has advantages and disadvantages. There is no with acquired disease of the outer retina. Five companies have performed Phase I clinical trials demonstrating that clear benefit to one approach or the other. blind patients can reliably report basic elements of visual The first attempt to build a visual prosthesis dates back to percepts induced by electrical stimulation. However, at the 1970s (1). In the late 1980s, 2 research groups, one present patients and observers generally do not consider based at the Massachusetts Eye and Ear Infirmary/Harvard the results to be useful enough in the performance of tasks Medical School and the Massachusetts Institute of Tech- of daily living to justify the risks of surgery and chronic implantation or the costs. Having developed a wireless nology and the other at the North Carolina State University device implanted in the subretinal space, the Boston Ret- and the Duke University, simultaneously began to in- inal Implant Project has focused its efforts on developing vestigate the development of a retinal prosthesis. The former scalable technologies to create a hermetic device that can consortium now includes the Boston Veterans Adminis- deliver individually controlled pulses of electrical stimula- tration Hospital as an integral partner.
    [Show full text]
  • Retinal Prostheses: Progress Toward the Next Generation Implants
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector MINI REVIEW published: 20 August 2015 doi: 10.3389/fnins.2015.00290 Retinal prostheses: progress toward the next generation implants Diego Ghezzi* Medtronic Chair in Neuroengineering, Center for Neuroprosthetics, Interfaculty Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland In the last decade, various clinical trials proved the capability of visual prostheses, in particular retinal implants, to restore a useful form of vision. These encouraging results promoted the emerging of several strategies for neuronal stimulation aiming at the restoration of sight. Besides the traditional approach based on electrical stimulation through metal electrodes in the different areas of the visual path (e.g., the visual cortex, the lateral geniculate nucleus, the optic nerve, and the retina), novel concepts for neuronal stimulation have been mostly exploited as building blocks of the next generation of retinal implants. This review is focused on critically discussing recent major advancements in Edited by: the field of retinal stimulation with particular attention to the findings in the application Michele Giugliano, of novel concepts and materials. Last, the major challenges in the field and their clinical University of Antwerp, Belgium implications will be outlined. Reviewed by: Guillermo Peris Fajarnes, Keywords: vision, retinal prosthesis, photovoltaic stimulation, thermal stimulation, ultrasonic stimulation University of Valencia, Spain Karl Farrow, Neuro-Electronics Research Flanders, Introduction Belgium *Correspondence: Low vision and blindness can result when any step of the visual pathway (the cornea, the lens, Diego Ghezzi, the retina, the optic nerve, the thalamus, and the visual cortex) is altered or sustains damage.
    [Show full text]
  • Cochlear Implant for the Deaf
    Introduction to Neural Prosthesis Sung June Kim Neural Prosthetic Engineering 1 Neural Prosthesis • A device that connects directly with the nervous system to replace or supplement sensory or motor function. • A device that improves the quality of life of a neurologically impaired individual so much that he/she is willing to put up with the surgery, gadgetry, etc. Neural Prosthetic Engineering 2 Successful Areas of Neural Prosthesis • (Bionic Ear) • Hearing: Cochlear Implant • Vision: Retinal Implant • Parkinson’s Disease: DBS (Deep Brain Stimulation) Neural Prosthetic Engineering 3 Why these three? • Success in Cochlear Implant • The other two were inspired by its (the CI’s) success. • The Cochlear and Retinal implants are sensory prosthetics, using electrical stimulation of neurons. • The DBS deals with motion disability yet uses CI like neuronal stimulation. Neural Prosthetic Engineering 4 Why was CI so successful? • Spatially isolated space was available for the electrode array. The electrode array was still electrically connected to the target neurons. • Timely development of the transistor based microelectronics technologies that made the electronics small (wearable, implantable) but powerful. http://www.cochlearamericas.com/ Neural Prosthetic Engineering 5 What are needed in NP? (1) • External unit is needed if there is a signal to process. • Speech is the signal to process in Cochlear Implant • Image is the signal to process in Retinal Implant • There is no external signal to process in DBS. External Unit Neural Prosthetic Engineering 6 Speech Processor, An example of External Unit 7 www. bionicear.com, www.medel.com, www.cochlear.com Neural Prosthetic Engineering What are needed in NP? (2) • Internal Unit (Implantable Unit) • This unit generates electrical signals, and apply them to the array of electrodes that stimulate target neurons.
    [Show full text]
  • THE 11TH WORLD CONGRESS on the Relationship Between Neurobiology and Nano-Electronics Focusing on Artificial Vision
    THE 11TH WORLD CONGRESS On the Relationship Between Neurobiology and Nano-Electronics Focusing on Artificial Vision November 10-12, 2019 The Henry, An Autograph Collection Hotel DEPARTMENT OF OPHTHALMOLOGY Detroit Institute of Ophthalmology Thank you to Friends of Vision for your support of the Bartimaeus Dinner The Eye and The Chip 2 DEPARTMENT OF OPHTHALMOLOGY Detroit Institute of Ophthalmology TABLE OF CONTENTS WELCOME LETTER—PAUL A. EDWARDS. M.D. ....................................................... WELCOME LETTER—PHILIP C. HESSBURG, M.D. ..................................................... DETROIT INSTITUTE OF OPHTHALMOLOGY ......................................................... ORGANIZING COMMITTEE/ACCREDITATION STATEMENT ............................................... CONGRESS 3-DAY SCHEDULE ................................................................... PLATFORM SPEAKER LIST ...................................................................... SPEAKER ABSTRACTS .......................................................................... POSTER PRESENTERS’ LIST ..................................................................... POSTER ABSTRACTS ........................................................................... BARTIMAEUS AWARD—PREVIOUS RECIPIENTS ...................................................... SUPPORTING SPONSORS . Audio-Visual Services Provided by Dynasty Media Network http://dynastymedianetwork.com/ The Eye and The Chip Welcome On behalf of the Henry Ford Health System and the Department of Ophthalmology,
    [Show full text]
  • The Bionic Eye…A New Vision of the Future
    International Journal of Science and Research (IJSR) ISSN: 2319-7064 ResearchGate Impact Factor (2018): 0.28 | SJIF (2019): 7.583 The Bionic Eye…A New Vision of the Future Abhinn D. Suthar1, Tejas R. Suthar2 1 MIT School of Bioengineering Science and Research, MIT ADT University, Pune, India 2MIT College of Food Technology, MIT ADT University, Pune, India (Correspondence Author) Abstract: Artificial vision is new emerging revolutionary technique that allows blind people to see. This can be possible by visual implants like either camera or photoreceptors array. A specialist can perform the best supernatural art of providing new vision to individual who has lost his/her visualizing power or eye sight. A visual prosthesis or bionic eye is a type of neural prosthesis expected to mostly re-establish lost vision or intensify existing vision brought about by a visual observation in patients with retinal pathologies like retinitis pigmentosa and age-related macular degeneration. In this article we have represented the different aspects related to technological advancement in implanting bionic eye. The essential capacity of the gadget to get the pictures utilizing a camera, convert it to electric signs and in the long run animate the left-over more advantageous pieces of the visual pathway. The embed visual prosthesis depends on a little chip that is precisely embedded behind the retina, at the rear of the eye ball. Virtual protheses like automated retinal systems are a new and innovative solution to extreme vision impairment care. We have also included the history of advancement in prosthetic and surgical process of embedding bionic eye.
    [Show full text]
  • India Vision 2020' a Possibility
    ISSN(Online) : 2319-8753 ISSN (Print) : 2347-6710 International Journal of Innovative Research in Science, Engineering and Technology (An ISO 3297: 2007 Certified Organization) Vol. 5, Issue 12, December 2016 VISION THROUGH ELECTRONICS- To make 'India Vision 2020' a Possibility V.Umaiyaal IV year Student, Dept of Biomedical Engineering, PSNA-CET, Kothandaraman Nagar, Dindigul, Tamil Nadu, India ABSTRACT: The dream of using electronic or artificial retinal replacements to treat blindness has long been held. In the development of prosthetic vision, it is also possible to stimulate the visual pathway at other sites other than the retina to gain visual perceptions The visual pathway functions as a complex image processor as well as an information conduit. At higher levels, the visual signals arrive with significant processing completed. Treatment options for the associated cataract and macular oedema, have been limited,retinal prostheses offer the only treatment option for patients at the severe end of the disease spectrum at present. There are currently two models of retinal prostheses available commercially: (i) Argus® II retinal prosthesis system (Second Sight Medical Product, Inc., Sylmar), which received CE (Conformité Européenne) marking in March 2011 and the Food and Drug Administration (FDA) approval in February 2013[3] and (ii) the alpha-IMS (Retinal Implant AG, Reutlingen), which obtained CE marking in July 2013.Apart from technological advances in prosthetic vision, development in other biomedical fields has also shed new hope on restoring vision in patients with end-stage retinal diseases, most notably the cellular therapy. This video camera is embedded in the inter-ocular bridge of the glasses frame.
    [Show full text]
  • Predicting Electrode Deactivation from Routine Clinical Measures
    medRxiv preprint doi: https://doi.org/10.1101/2021.03.07.21253092; this version posted March 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Explainable AI for Retinal Prostheses: Predicting Electrode Deactivation from Routine Clinical Measures Zuying Hu1 and Michael Beyeler2 Abstract— To provide appropriate levels of stimulation, reti- strategy exists for retinal implant recipients. Repeated system nal prostheses must be calibrated to an individual’s perceptual fitting would be time-consuming at best and quickly become thresholds (‘system fitting’). Nonfunctional electrodes may then infeasible as new retinal prostheses are being developed that be deactivated to reduce power consumption and improve visual outcomes. However, thresholds vary drastically not just feature thousands of electrodes. across electrodes but also over time, thus calling for a more To address these challenges, we developed an explainable flexible electrode deactivation strategy. Here we present an artificial intelligence (XAI) model that could 1) predict at explainable artificial intelligence (XAI) model fit on a large which point in time an individual Argus II electrode was longitudinal dataset that can 1) predict at which point in deactivated as a function of routinely collected clinical mea- time the manufacturer chose to deactivate an electrode as a function of routine clinical measures (‘predictors’) and 2) reveal sures (‘predictors’), and 2) reveal which of these predictors which of these predictors were most important. The model were most important.
    [Show full text]
  • By Owen Burke • a Prosthetic Eye Or Bionic Eye, Is a Technological Device That Aims to Restore Basic Vision to People Suffering Degenerative Blinding Diseases
    By Owen Burke • A prosthetic eye or bionic eye, is a technological device that aims to restore basic vision to people suffering degenerative blinding diseases. • Most sight loss is caused by problems with the retina such as retinitis pigmentosa or age related macular degeneration. • More than 20 million people around the world are blind or at risk of blindness due to these retinal diseases. Typically they destroy the light-sensitive photoreceptors Diagram of difference between (absorbers of visible light radiation) normal eye and retinitis in the retina, but leave nerve pigmentosa affected eye connections to the brain intact. • By replacing these photoreceptors with artificial ones, it is hoped that some level of sight can be restored. • To date, results have been disappointing. Although some sight can be restored, serious visual impairment still remains. • However, recently design breakthroughs have been made and people around the world can begin to hope that their problems can be solved. • Other treatments can be used to help with the degenerative diseases such as certain drugs, but these will only slow down the process of loosing sight. For most, their main hope lies in prosthetic devices. 1. Light enters the eye through the cornea, the clear transparent front who's refractive power bends the light in such a way that it can pass freely through the pupil. 2. The pupil is in the middle of the iris (the coloured part of our eye). The iris is like a camera shutter, it has the ability to enlarge or shrink depending on how much light is coming through.
    [Show full text]
  • An Overview of the Internet of Things for People with Disabilities
    Journal of Network and Computer Applications 35 (2012) 584–596 Contents lists available at SciVerse ScienceDirect Journal of Network and Computer Applications journal homepage: www.elsevier.com/locate/jnca Review An overview of the Internet of Things for people with disabilities Mari Carmen Domingo n Electrical Engineering, UPC-Barcelona Tech University, Esteve Terradas, 7, 08860 Castelldefels (Barcelona), Spain article info abstract Article history: Currently, over a billion people including children (or about 15% of the world’s population) are Received 30 June 2011 estimated to be living with disability. The lack of support services can make handicapped people overly Received in revised form dependent on their families, which prevents them from being economically active and socially 18 September 2011 included. The Internet of Things can offer people with disabilities the assistance and support they Accepted 20 October 2011 need to achieve a good quality of life and allows them to participate in the social and economic life. In Available online 29 October 2011 this paper, an overview of the Internet of Things for people with disabilities is provided. For this Keywords: purpose, the proposed architecture of the Internet of Things is introduced. Different application Internet of Things scenarios are considered in order to illustrate the interaction of the components of the Internet of People with disabilities Things. Critical challenges have been identified and addressed. Architecture & 2011 Elsevier Ltd. All rights reserved. Applications
    [Show full text]
  • Addressing the Challenges of Visually Impaired Using Iot
    International Journal on Recent and Innovation Trends in Computing and Communication ISSN: 2321-8169 Volume: 5 Issue: 1 182 – 186 _______________________________________________________________________________________________ Addressing the challenges of Visually Impaired using IoT Vanishree M L Sushmitha S Roopa B K Department of CSE Department of CSE Department of CSE Global Academy of Technology Global Academy of Technology Global Academy of Technology Bangalore- 560098 Bangalore- 560098 Bangalore- 560098 [email protected] [email protected] [email protected] Abstract— Internet of Things is a new revolution of the Internet. IoT allows networked objects to be sensed and controlled remotely, creating opportunities for more direct integration of the physical world into computer-based systems, resulting in reduced human intervention. People with complete blindness or low vision often have a difficult time self-navigating in unusual environments. In fact, mobility is one of the biggest challenges for visually Impaired. IoT offers the assistance and support to the visually impaired people to achieve a quality life allowing them to involve in social activities. Assistive IoT technologies are powerful tools to increase independence and improve participation. Therefore, the purpose of this paper is to analyze how people with visual impairment can interact with and benefit from the IoT. Keywords- Internet of Things (IoT), visually impaired, assistive technology, sensors, actuators, mobility. __________________________________________________*****_________________________________________________
    [Show full text]
  • A Review of Retinal Prosthesis Approaches
    International Conference Mathematical and Computational Biology 2011 International Journal of Modern Physics: Conference Series Vol. 9 (2012) 209–231 World Scientific Publishing Company DOI: 10.1142/S2010194512005272 A REVIEW OF RETINAL PROSTHESIS APPROACHES TRAN TRUNG KIEN School of Computer Science, The University of Nottingham Malaysia Campus, Jalan Broga, Semenyih, Selangor 43500, Malaysia [email protected] TOMAS MAUL School of Computer Science, The University of Nottingham Malaysia Campus, Jalan Broga, Semenyih, Selangor 43500, Malaysia [email protected] ANDRZEJ BARGIELA School of Computer Science, The University of Nottingham, Nottingham, NG8 1BB [email protected] Age-related macular degeneration and retinitis pigmentosa are two of the most common diseases that cause degeneration in the outer retina, which can lead to several visual impairments up to blindness. Vision restoration is an important goal for which several different research approaches are currently being pursued. We are concerned with restoration via retinal prosthetic devices. Prostheses can be implemented intraocularly and extraocularly, which leads to different categories of devices. Cortical Prostheses and Optic Nerve Prostheses are examples of extraocular solutions while Epiretinal Prostheses and Subretinal Prostheses are examples of intraocular solutions. Some of the prostheses that are successfully implanted and tested in animals as well as humans can restore basic visual functions but still have limitations. This paper will give an overview of the current state of art of Retinal Prostheses and compare the advantages and limitations of each type. The purpose of this review is thus to summarize the current technologies and approaches used in developing Retinal Prostheses and therefore to lay a foundation for future designs and research directions.
    [Show full text]
  • What Do Blind People “See” with Retinal Prostheses? Observations And
    bioRxiv preprint doi: https://doi.org/10.1101/2020.02.03.932905; this version posted February 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 What do blind people “see” with retinal prostheses? Observations and qualitative reports of epiretinal 2 implant users 3 4 5 6 Cordelia Erickson-Davis1¶* and Helma Korzybska2¶* 7 8 9 10 11 1 Stanford School of Medicine and Stanford Anthropology Department, Stanford University, Palo Alto, 12 California, United States of America 13 14 2 Laboratory of Ethnology and Comparative Sociology (LESC), Paris Nanterre University, Nanterre, France 15 16 17 18 19 * Corresponding author. 20 E-mail: [email protected], [email protected] 21 22 23 ¶ The authors contributed equally to this work. 24 25 26 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.02.03.932905; this version posted February 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 27 Abstract 28 29 Introduction: Retinal implants have now been approved and commercially available for certain 30 clinical populations for over 5 years, with hundreds of individuals implanted, scores of them closely 31 followed in research trials. Despite these numbers, however, few data are available that would help 32 us answer basic questions regarding the nature and outcomes of artificial vision: what do 33 participants see when the device is turned on for the first time, and how does that change over time? 34 35 Methods: Semi-structured interviews and observations were undertaken at two sites in France and 36 the UK with 16 participants who had received either the Argus II or IRIS II devices.
    [Show full text]